ISRPerspective Therapeutics Inc


$ 1.08 $ -0.09 (-7.76 %)    

Friday, 14-Jun-2024 15:59:59 EDT
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 1.07
$ 1.26
$ 0.00 x 0
$ 0.00 x 0
$ 1.05 - $ 1.26
$ 0.21 - $ 1.91
8,634,090
na
na
$ 0.73
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 isoray-q2-eps-002-down-from-001-yoy-sales-183m-down-from-282m-yoy

IsoRay (AMEX:ISR) reported quarterly losses of $(0.02) per share. This is a 100 percent decrease over losses of $(0.01) per sha...

 isoray-says-on-feb-1-lori-woods-resigned-as-ceo-board-names-johan-spoor-as-ceo-michael-mccormick-also-gave-notice-of-resignation-of-chairman-of-board

-SEC Filing

 vapotherm-redwire-and-these-2-penny-stocks-insiders-are-aggressively-buying

The Dow Jones closed lower by nearly 500 points on Monday. Investors, meanwhile, focused on some notable insider trades. When ...

 isoray-and-manufacturing-partner-gt-medical-technologies-have-received-fda-510k-clearance-for-gammatile-likely-for-a-new-indication---fda

510(k) Premarket Notification (fda.gov)

 earnings-scheduled-for-november-10-2022

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report earnings for its third quarter.

 why-oil-related-stocks-traded-higher-here-are-74-biggest-movers-from-yesterday

Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announ...

 why-senti-biosciences-shares-jumped-over-50-here-are-79-biggest-movers-from-yesterday

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares climbed 50.7% to close at $2.11 on Thursday after B of A Securities in...

 dow-falls-600-points-sp-500-down-25

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 600 points on Thursday.

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 930 stocks hit new 52-week lows.

 why-sunlight-financial-shares-are-trading-lower-by-59-here-are-54-stocks-moving-in-thursdays-mid-day-session

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares jumped 52% to $2.1325 after B of A Securities initiated coverage on th...

 isoray-q4-eps-001-inline-sales-250m-miss-284m-estimate

IsoRay (AMEX:ISR) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is unchanged fr...

 isoray-to-acquire-viewpoint-molecular-targeting-inc-a-newly-formed-wholly-owned-subsidiary-of-isoray-will-merge-with-and-into-viewpoint-with-viewpoint-becoming-a-wholly-owned-subsidiary-of-isoray

Isoray, Inc. (NYSE:ISR), a medical technology company and innovator in seed brachytherapy, today announced that it has entered ...

 earnings-scheduled-for-september-28-2022

Companies Reporting Before The Bell • Lilium (NASDAQ:LILM) is expected to report earnings for its second quarter.

 isoray-earnings-preview
IsoRay Earnings Preview
09/27/2022 14:13:46

IsoRay (AMEX:ISR) is set to give its latest quarterly earnings report on Wednesday, 2022-09-28. Here's what investors need...

 isorays-cesium-131-featured-in-presentations-at-american-brachytherapy-societys-annual-conference

The growing body of information regarding Isoray, Inc.'s (NYSE:ISR) Cesium-131 in treating prostate cancer was highlighted ...

 isoray-q3-eps-001-same-yoy-sales-291m-miss-311m-estimate

IsoRay (AMEX:ISR) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The compan...

 earnings-scheduled-for-may-10-2022

  Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per shar...

 stocks-that-hit-52-week-lows-on-tuesday

  During Tuesday's session, 454 stocks hit new 52-week lows.

 isorays-cesium-131--radiation-therapy-shows-favorable-outcomes-in-prostate-cancer

Investigators from the University of Pittsburgh School of Medicine have published a